Open AccessMyocardial Revascularization in COVID-19 Era
Author(s) -
Sasmojo Widito
Publication year - 2021
Publication title -
heart science journal
Language(s) - English
Resource type - Journals
eISSN - 2721-9984
pISSN - 2721-9976
DOI - 10.21776/ub.hsj.2021.002.03.1
Subject(s) - covid-19 , medicine , pandemic , acute coronary syndrome , revascularization , intensive care medicine , disease , cardiac catheterization , cardiology , virology , myocardial infarction , infectious disease (medical specialty) , outbreak
Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by the coronavirus 2 that causes severe acute respiratory syndrome (SARS-CoV-2). More discussion is required to achieve the balance between clinical benefit and risk in the treatment of acute coronary syndrome (ACS) patients with COVID-19. The current COVID-19 pandemic prompts the need to evaluate criteria for indication and efficacy of the general safety protocols and particular cardiac catheterization laboratory (CCL) procedures to safeguard the patient and healthcare professionals